182 research outputs found
Long-time dynamics of Rouse-Zimm polymers in dilute solutions with hydrodynamic memory
The dynamics of flexible polymers in dilute solutions is studied taking into
account the hydrodynamic memory, as a consequence of fluid inertia. As distinct
from the Rouse-Zimm (RZ) theory, the Boussinesq friction force acts on the
monomers (beads) instead of the Stokes force, and the motion of the solvent is
governed by the nonstationary Navier-Stokes equations. The obtained generalized
RZ equation is solved approximately. It is shown that the time correlation
functions describing the polymer motion essentially differ from those in the RZ
model. The mean-square displacement (MSD) of the polymer coil is at short times
\~ t^2 (instead of ~ t). At long times the MSD contains additional (to the
Einstein term) contributions, the leading of which is ~ t^(1/2). The relaxation
of the internal normal modes of the polymer differs from the traditional
exponential decay. It is displayed in the long-time tails of their correlation
functions, the longest-lived being ~ t^(-3/2) in the Rouse limit and t^(-5/2)
in the Zimm case, when the hydrodynamic interaction is strong. It is discussed
that the found peculiarities, in particular an effectively slower diffusion of
the polymer coil, should be observable in dynamic scattering experiments.Comment: 6 page
Infrared Spectra and Ab Initio Calculations for the F-−(CH4)n (n = 1−8) Anion Clusters
Infrared spectra of mass-selected F-−(CH4)n (n = 1−8) clusters are recorded in the CH stretching region (2500−3100 cm-1). Spectra for the n = 1−3 clusters are interpreted with the aid of ab initio calculations at the MP2/6-311++G(2df 2p) level, which suggest that the CH4ligands bind to F- by equivalent, linear hydrogen bonds. Anharmonic frequencies for CH4 and F-−CH4 are determined using the vibrational self-consistent field method with second-order perturbation theory correction. The n = 1 complex is predicted to have a C3v structure with a single CH group hydrogen bonded to F-. Its spectrum exhibits a parallel band associated with a stretching vibration of the hydrogen-bonded CH group that is red-shifted by 380 cm-1 from the ν1 band of free CH4 and a perpendicular band associated with the asymmetric stretching motion of the nonbonded CH groups, slightly red-shifted from the ν3 band of free CH4. As nincreases, additional vibrational bands appear as a result of Fermi resonances between the hydrogen-bonded CH stretching vibrational mode and the 2ν4 overtone and ν2 + ν4combination levels of the methane solvent molecules. For clusters with n ≤ 8, it appears that the CH4 molecules are accommodated in the first solvation shell, each being attached to the F- anion by equivalent hydrogen bonds
Diffusing-wave spectroscopy of nonergodic media
We introduce an elegant method which allows the application of diffusing-wave
spectroscopy (DWS) to nonergodic, solid-like samples. The method is based on
the idea that light transmitted through a sandwich of two turbid cells can be
considered ergodic even though only the second cell is ergodic. If absorption
and/or leakage of light take place at the interface between the cells, we
establish a so-called "multiplication rule", which relates the intensity
autocorrelation function of light transmitted through the double-cell sandwich
to the autocorrelation functions of individual cells by a simple
multiplication. To test the proposed method, we perform a series of DWS
experiments using colloidal gels as model nonergodic media. Our experimental
data are consistent with the theoretical predictions, allowing quantitative
characterization of nonergodic media and demonstrating the validity of the
proposed technique.Comment: RevTeX, 12 pages, 6 figures. Accepted for publication in Phys. Rev.
Molecular velocity auto-correlation of simple liquids observed by NMR MGSE method
The velocity auto-correlation spectra of simple liquids obtained by the NMR
method of modulated gradient spin echo show features in the low frequency range
up to a few kHz, which can be explained reasonably well by a long
time tail decay only for non-polar liquid toluene, while the spectra of polar
liquids, such as ethanol, water and glycerol, are more congruent with the model
of diffusion of particles temporarily trapped in potential wells created by
their neighbors. As the method provides the spectrum averaged over ensemble of
particle trajectories, the initial non-exponential decay of spin echoes is
attributed to a spatial heterogeneity of molecular motion in a bulk of liquid,
reflected in distribution of the echo decays for short trajectories. While at
longer time intervals, and thus with longer trajectories, heterogeneity is
averaged out, giving rise to a spectrum which is explained as a combination of
molecular self-diffusion and eddy diffusion within the vortexes of hydrodynamic
fluctuations.Comment: 8 pages, 6 figur
Haemodynamic, endocrine and renal actions of adrenomedullin 5 in an ovine model of heart failure
AM5 (adrenomedullin 5), a newly described member of the CGRP (calcitonin gene-related peptide) family, is reported to play a role in normal cardiovascular physiology. The effects of AM5 in HF (heart failure), however, have not been investigated. In the present study, we intravenously infused two incremental doses of AM5 (10 and 100 ng/min per kg of body weight each for 90 min) into eight sheep with pacing-induced HF. Compared with time-matched vehicle control infusions, AM5 produced progressive and dose-dependent increases in left ventricular dP/dt(max) [LD (low dose), +56 mmHg/s and HD (high dose), +152 mmHg/s] and cardiac output (+0.83 l/min and +1.81 l/min), together with decrements in calculated total peripheral resistance (−9.4 mmHg/min per litre and −14.7 mmHg/min per litre), mean arterial pressure (−2.8 mmHg and −8.4 mmHg) and LAP (left atrial pressure; −2.6 mmHg and −5.6 mmHg) (all P<0.001). HD AM5 significantly raised PRA (plasma renin activity) (3.5-fold increment, P<0.001), whereas plasma aldosterone levels were unchanged over the intra-infusion period and actually fell in the post-infusion period (70% decrement, P<0.01), resulting in a marked decrease in the aldosterone/PRA ratio (P<0.01). Despite falls in LAP, plasma atrial natriuretic peptide and B-type natriuretic peptide concentrations were maintained relative to controls. AM5 infusion also induced significant increases in urine volume (HD 2-fold increment, P<0.05) and urine sodium (2.7-fold increment, P<0.01), potassium (1.7-fold increment, P<0.05) and creatinine (1.4-fold increment, P<0.05) excretion and creatinine clearance (60% increment, P<0.05). In conclusion, AM5 has significant haemodynamic, endocrine and renal actions in experimental HF likely to be protective and compensatory in this setting. These results suggest that AM5 may have potential as a therapeutic agent in human HF
Simulation of dilated heart failure with continuous flow circulatory support
Lumped parameter models have been employed for decades to simulate important hemodynamic couplings between a left ventricular assist device (LVAD) and the native circulation. However, these studies seldom consider the pathological descending limb of the Frank-Starling response of the overloaded ventricle. This study introduces a dilated heart failure model featuring a unimodal end systolic pressure-volume relationship (ESPVR) to address this critical shortcoming. The resulting hemodynamic response to mechanical circulatory support are illustrated through numerical simulations of a rotodynamic, continuous flow ventricular assist device (cfVAD) coupled to systemic and pulmonary circulations with baroreflex control. The model further incorporated septal interaction to capture the influence of left ventricular (LV) unloading on right ventricular function. Four heart failure conditions were simulated (LV and bi-ventricular failure with/ without pulmonary hypertension) in addition to normal baseline. Several metrics of LV function, including cardiac output and stroke work, exhibited a unimodal response whereby initial unloading improved function, and further unloading depleted preload reserve thereby reducing ventricular output. The concept of extremal loading was introduced to reflect the loading condition in which the intrinsic LV stroke work is maximized. Simulation of bi-ventricular failure with pulmonary hypertension revealed inadequacy of LV support alone. These simulations motivate the implementation of an extremum tracking feedback controller to potentially optimize ventricular recovery. © 2014 Wang et al
Myocardial Hypertrophy Overrides the Angiogenic Response to Hypoxia
Background: Cyanosis and myocardial hypertrophy frequently occur in combination. Hypoxia or cyanosis can be potent inducers of angiogenesis, regulating the expression of hypoxia-inducible factors (HIF), vascular endothelial growth factors (VEGF), and VEGF receptors (VEGFR-1 and 2); in contrast, pressure overload hypertrophy is often associated with impaired pro-angiogenic signaling and decreased myocardial capillary density. We hypothesized that the physiological pro-angiogenic response to cyanosis in the hypertrophied myocardium is blunted through differential HIF and VEGF-associated signaling. Methods and Results: Newborn rabbits underwent aortic banding and, together with sham-operated littermates, were transferred into a hypoxic chamber (FiO2 = 0.12) at 3 weeks of age. Control banded or sham-operated rabbits were housed in normoxia. Systemic cyanosis was confirmed (hematocrit, arterial oxygen saturation, and serum erythropoietin). Myocardial tissue was assayed for low oxygen concentrations using a pimonidazole adduct. At 4 weeks of age, HIF-1α and HIF-2α protein levels, HIF-1α DNA-binding activity, and expression of VEGFR-1, VEGFR-2, and VEGF were determined in hypoxic and normoxic rabbits. At 6 weeks of age, left-ventricular capillary density was assessed by immunohistochemistry. Under normoxia, capillary density was decreased in the banded rabbits compared to non-banded littermates. As expected, non-hypertrophied hearts responded to hypoxia with increased capillary density; however, banded hypoxic rabbits demonstrated no increase in angiogenesis. This blunted pro-angiogenic response to hypoxia in the hypertrophied myocardium was associated with lower HIF-2α and VEGFR-2 levels and increased HIF-1α activity and VEGFR-1 expression. In contrast, non-hypertrophied hearts responded to hypoxia with increased HIF-2α and VEGFR-2 expression with lower VEGFR-1 expression. Conclusion: The participation of HIF-2α and VEGFR-2 appear to be required for hypoxia-stimulated myocardial angiogenesis. In infant rabbit hearts with pressure overload hypertrophy, this pro-angiogenic response to hypoxia is effectively uncoupled, apparently in part due to altered HIF-mediated signaling and VEGFR subtype expression
Vasodilators in the treatment of acute heart failure: what we know, what we don’t
Although we have recently witnessed substantial progress in management and outcome of patients with chronic heart failure, acute heart failure (AHF) management and outcome have not changed over almost a generation. Vasodilators are one of the cornerstones of AHF management; however, to a large extent, none of those currently used has been examined by large, placebo-controlled, non-hemodynamic monitored, prospective randomized studies powered to assess the effects on outcomes, in addition to symptoms. In this article, we will discuss the role of vasodilators in AHF trying to point out which are the potentially best indications to their administration and which are the pitfalls which may be associated with their use. Unfortunately, most of this discussion is only partially evidence based due to lack of appropriate clinical trials. In general, we believe that vasodilators should be administered early to AHF patients with normal or high blood pressure (BP) at presentation. They should not be administered to patients with low BP since they may cause hypotension and hypoperfusion of vital organs, leading to renal and/or myocardial damage which may further worsen patients’ outcome. It is not clear whether vasodilators have a role in either patients with borderline BP at presentation (i.e., low-normal) or beyond the first 1–2 days from presentation. Given the limitations of the currently available clinical trial data, we cannot recommend any specific agent as first line therapy, although nitrates in different formulations are still the most widely used in clinical practice
- …